Drug Shortage Report for (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP
Report ID | 257307 |
Drug Identification Number | 00437999 |
Brand name | (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP |
Common or Proper name | test |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM CHLORIDE SODIUM CHLORIDE DEXTROSE |
Strength(s) | 150MG 450MG 5G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1234 |
ATC code | B05BB |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2021-03-02 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-09-07 |
Company comments | test company comments |
Health Canada comments | test HC comments |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2025-09-07 | French | Compare |
v3 | 2025-09-07 | French | Compare |
v2 | 2025-09-07 | French | Compare |
v1 | 2025-09-07 | English | Compare |
Showing 1 to 4 of 4